RICHMOND, Va., May 14, 2002 (PRIMEZONE) -- A Biotech/Genomics Stocks Forum featuring three companies and an industry expert will be held virtually, on May 22. The event is open to the public and will take place online at www.informedinvestors.com. By attending this Forum, investors can hear directly from company executives and get their investment information straight from the source.
The event, produced by Informed Investors, will take place from 8:00 a.m. to 11:00 p.m. Information is available at www.informedinvestors.com or by calling 888-301-6618.
Current and potential investors will hear from Biotech sector companies including Executives from each company will give 20 minute analyst-style presentations, question and comments can be made via email during and after each presentation.
John McCamant will deliver the keynote address. McCamant joined The Medical Technology Stock Letter (MTSL) as associate editor in 1987 and was named editor of the publication in August 2000. MTSL is a source for analysis and advice about investing in biotechnology companies. It was the top performing financial advisory newsletter over the past 5 years according to the December 12, 2001 issue of the Hulbert Financial Digest. In addition, Hulbert ranks MTSL in the top 5 performing newsletters over the past 15 years. Mr. McCamant has established an extensive network that includes contacts throughout the investment banking and venture capital communities and his expertise in biotechnology investments has become a great source of media interest as seen in such places as The Washington Post, Yahoo!Finance, Business Week, Reuter's, Worth, and on CNN and CNBC.
Aastrom Biosciences, Inc. (Nasdaq:ASTM) is developing automated cell therapy systems designed to enable on-site cell production for therapeutic procedures using living cells in patients treated for cancer and other diseases and cells used in the restoration of normal tissues.
AlphaRx (ALRX) is an emerging pharmaceutical company specializing in the formulation of therapeutic products using proprietary drug delivery technologies. AlphaRx's core competent is in the development of novel drug formulations for compounds that are otherwise insoluble or poorly soluble in water. AlphaRx's technology is versatile and offers significant flexibility in the development of suitable dosage formulations (i.e. Immediate Release or Controlled Release) to meet the requirements of specific drug molecules.
Neurobiological Technologies, Inc. (NTI(r)) (Nasdaq:NTII), is an emerging drug development company focused on the clinical development and regulatory approval of neuroscience drugs. The company develops neuroprotective and neuromodulatory agents to treat progressive neurological impairments characteristic of various nervous system disorders, including diabetic neuropathy, brain cancer, and AIDS dementia syndrome.
Informed Investors is the leading producer of online and offline industry-specific investment conferences for individual investors and a member of the WILink family of companies serving self-reliant investors.
About WILink: Since 1992, WILink (www.wilink.com) has opened information channels between public companies and potential investors. WILink is an investor relations and investment services group that markets a range of services that help publicly traded companies and mutual funds attract and retain well informed investors, while providing investors with access to information to make well informed investment decisions. This year WILink will make more than 7 million investor introductions to over 4,200 corporate clients through services including The Annual Reports Service, The Fund Info Service, Vcall (www.vcall.com) Investor Conference (www.investorconference.com) and Informed Investors Forums (www.informedinvestors.com). These services provide investors free access to onsite and webcast investor events and company financial reports through WILink's relationships with over 220 leading financial media channels in 14 countries including The Wall Street Journal, Financial Times, Barron's and Yahoo!Finance. For companies and mutual funds, these services enable compliance with regulation fair-disclosure requirements and provide visibility with investors at the precise point investors are making decisions. WILink, Inc. a wholly owned subsidiary of WILink.com plc (WLK on The London Stock Exchange) began operations in Richmond, Va. in 1993.